Quarterly report pursuant to Section 13 or 15(d)

Share-Based Payments

v2.4.0.6
Share-Based Payments
6 Months Ended
Jun. 30, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Payments
Share-Based Payments

The Company’s general practice has been to make a single annual grant of share-based compensation to key employees and to make other employee grants only in connection with new employment or promotions.  Forms of share-based compensation granted to employees by the Company include stock options, non-vested shares of common stock (“non-vested share”), and performance shares.  The Company also typically makes a single annual grant of non-vested shares to non-employee directors in conjunction with the annual election of non-employee directors to the Board of Directors.  Share-based compensation is based on the grant date fair value of the instrument and is recognized, net of estimated forfeitures, ratably over the requisite service period, or vesting period. The Company estimates forfeitures based upon historical experience.  All share-based compensation expense is recognized in salaries, wages and employee benefits.

Employee Activity - Stock Options
 
Stock option grants to employees typically expire seven years from the grant date and vest ratably over a three-year period.  The Company used the Black-Scholes option-pricing model to estimate the grant-date fair value of options granted.  The weighted-average fair value of options granted and assumptions used to calculate their fair value during the six months ended June 30, 2012 and 2011 were as follows:


Six months ended

June 30,
2012

June 30,
2011
Expected dividend yield
0.9
%

1.0
%
Expected stock price volatility
46.6
%

44.9
%
Weighted average risk-free interest rate
0.8
%

2.4
%
Expected life of options (years)
4.2


4.6

Weighted average grant date fair value
$
13


$
11


The following tables summarize the Company’s employee stock option activity and related information:
 

Three months ended June 30, 2012







Weighted-



Weighted-

Aggregate

Average



Average

Intrinsic

Remaining

Options

Exercise

Value

Contractual

(000)

Price

(000)

Term
Outstanding at March 31, 2012
3,148


$
27





Granted







Exercised
(10
)

25





Outstanding at June 30, 2012
3,138


$
27


$
20,082


3.0

Exercisable at June 30, 2012
2,745


$
26


$
17,748


2.7



Three months ended

June 30,
2012

June 30,
2011
Shared-based compensation for options
$
596


$
952

Tax benefit for option compensation
$
164


$
252

Unrecognized compensation cost for options, net of estimated forfeitures
$
2,669


$
4,727


 

Six months ended June 30, 2012







Weighted-



Weighted-

Aggregate

Average



Average

Intrinsic

Remaining

Options

Exercise

Value

Contractual

(000)

Price

(000)

Term
Outstanding at December 31, 2011
3,363


$
26





Granted
93


37





Exercised
(318
)

27





Outstanding at June 30, 2012
3,138


$
27


$
20,082


3.0

Exercisable at June 30, 2012
2,745


$
26


$
17,748


2.7



Six months ended

June 30,
2012

June 30,
2011
Shared-based compensation for options
$
1,418


$
2,064

Tax benefit for option compensation
$
378


$
556

Unrecognized compensation cost for options, net of estimated forfeitures
$
2,669


$
4,727



Employee Activity - Non-vested Shares

Non-vested share grants to employees vest ratably over a three-year period.  The non-vested shares’ fair values were estimated using closing market prices on the day of grant. The following tables summarize the Company’s employee non-vested share activity and related information:


Three months ended June 30, 2012



Weighted-

Aggregate

Non-vested

Average

Grant Date

Shares

Grant Date

Fair Value

(000)

Fair Value

(000)
Outstanding and non-vested at March 31, 2012
175


$
33



Granted





Vested





Forfeited
(1
)

$
37



Outstanding and non-vested at June 30, 2012
174


$
33


$
5,780



Three months ended

June 30,
2012

June 30,
2011
Shared-based compensation for non-vested shares
$
552


$
252

Tax benefit for non-vested share compensation
$
212


$
100

Unrecognized compensation cost for non-vested shares, net of estimated forfeitures
$
4,735


$
2,601



Six months ended June 30, 2012



Weighted-

Aggregate

Non-vested

Average

Grant Date

Shares

Grant Date

Fair Value

(000)

Fair Value

(000)
Outstanding and non-vested at December 31, 2011
108


$
29



Granted
103


37



Vested
(36
)

29



Forfeited
(1
)

37



Outstanding and non-vested at June 30, 2012
174


$
33


$
5,780



Six months ended

June 30,
2012

June 30,
2011
Shared-based compensation for non-vested shares
$
997


$
388

Tax benefit for non-vested share compensation
$
384


$
154

Unrecognized compensation cost for non-vested shares, net of estimated forfeitures
$
4,735


$
2,601



Employee Activity - Performance Shares

In 2011 and 2012, the Company granted performance shares to key employees.  Under the terms of the performance share agreements, on the third anniversary of the grant date, the Company will issue to the employees a calculated number of common stock shares based on the three year performance of the Company’s common stock share price as compared to the share price performance of a selected peer group.  No shares may be issued if the Company share price performance outperforms 30% or less of the peer group, but the number of shares issued may be doubled if the Company share price performs better than 90% of the peer group.  The fair value of the performance shares was estimated using a Monte Carlo simulation. The weighted average assumptions used in the Monte Carlo calculation were as follows:


Six months ended

June 30,
2012

June 30,
2011
Expected stock price volatility
40.8
%

47.7
%
Weighted average risk-free interest rate
0.4
%

1.4
%

The following tables summarize the Company’s employee performance share activity, assuming median share awards, and related information:

Three months ended June 30, 2012



Weighted-

Aggregate

Performance

Average

Grant Date

Shares

Grant Date

Fair Value

(000)

Fair Value

(000)
Outstanding and non-vested at March 31, 2012
62


$
36



Granted





Vested





Outstanding and non-vested at June 30, 2012
62


$
36


$
2,205



Three months ended

June 30,
2012

June 30,
2011
Shared-based compensation for performance shares
$
183


$
94

Tax benefit for performance share compensation
$
70


$
37

Unrecognized compensation cost for performance shares, net of estimated forfeitures
$
1,541


$
988



Six months ended June 30, 2012



Weighted-

Aggregate

Performance

Average

Grant Date

Shares

Grant Date

Fair Value

(000)

Fair Value

(000)
Outstanding and non-vested at December 31, 2011
38


$
30



Granted
24


45



Vested





Outstanding and non-vested at June 30, 2012
62


$
36


$
2,205



Six months ended

June 30,
2012

June 30,
2011
Shared-based compensation for performance shares
$
330


$
145

Tax benefit for performance share compensation
$
127


$
57

Unrecognized compensation cost for performance shares, net of estimated forfeitures
$
1,541


$
988



Employee Activity - Employee Stock Purchase Plan
Under the 2005 Employee Stock Purchase Plan (the “ESPP”), which has been approved by shareholders, the Company is authorized to issue up to a remaining 425,848 shares of common stock to employees of the Company. These shares may be issued at a price equal to 90% of the lesser of the market value on the first day or the last day of each six-month purchase period. Common stock purchases are paid for through periodic payroll deductions and/or up to two large lump sum contributions. For the six months ended June 30, 2012, participants under the plan purchased 4,121 shares at an average price of $29.04 per share. For the six months ended June 30, 2011, participants under the plan purchased 4,941 shares at an average price of $25.82 per share. The weighted-average fair value of each purchase right under the ESPP granted for the six months ended June 30, 2012, which is equal to the discount from the market value of the common stock at the end of each six month purchase period, was $3.23 per share. The weighted-average fair value of each purchase right under the ESPP granted for the six months ended June 30, 2011, which is equal to the discount from the market value of the common stock at the end of each six month purchase period, was $7.97 per share. Share-based compensation expense of $13 and $40 was recognized during the six months ended June 30, 2012 and 2011, respectively.

Non-employee Director Activity - Non-vested Shares

Grants of non-vested shares to non-employee directors vest ratably over the elected term to the Board of Directors, or one year.  The following tables summarize the Company’s non-employee non-vested share activity and related information:

Three months ended June 30, 2012



Weighted-

Aggregate

Non-vested

Average

Grant Date

Shares

Grant Date

Fair Value

(000)

Fair Value

(000)
Outstanding and non-vested at March 31, 2012
22


$
33



Granted
20


32



Vested
(22
)

33



Outstanding and non-vested at June 30, 2012
20


$
32


$
640



Three months ended

June 30,
2012

June 30,
2012
Shared-based compensation for non-vested shares
$
173


$
180

Tax benefit for non-vested share compensation
$
67


$
72

Unrecognized compensation cost for non-vested shares, net of estimated forfeitures
$
546


$
660



Six months ended June 30, 2012



Weighted-

Aggregate

Non-vested

Average

Grant Date

Shares

Grant Date

Fair Value

(000)

Fair Value

(000)
Outstanding and non-vested at December 31, 2011
24


$
33



Granted
20


32



Vested
(24
)

33



Outstanding and non-vested at June 30, 2012
20


$
32


$
640



Six months ended

June 30,
2012

June 30,
2011
Shared-based compensation for non-vested shares
$
365


$
318

Tax benefit for non-vested share compensation
$
141


$
126

Unrecognized compensation cost for non-vested shares, net of estimated forfeitures
$
546


$
660


Non-employee Director Activity - Stock Options

In addition to the above activity, each May from 1995 to 2005 options were granted to the non-employee directors of the Company.  The options have terms of ten years and are fully exercisable.  At June 30, 2012, 40,625 options were outstanding and will expire between May 2013 and May 2015.  At June 30, 2012, the weighted average exercise price per share and remaining contractual term for the outstanding options of non-employee directors were $21 and 2.0 years, respectively.